These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
238 related items for PubMed ID: 12203663
21. Once weekly recombinant human erythropoietin treatment for cancer-induced anemia in children with acute lymphoblastic leukemia receiving maintenance chemotherapy: a randomized case-controlled study. Abdelrazik N, Fouda M. Hematology; 2007 Dec; 12(6):533-41. PubMed ID: 17852440 [Abstract] [Full Text] [Related]
22. Increased hemoglobin levels and improved quality-of-life assessments during epoetin alfa treatment in anemic cancer patients: results of a prospective, multicenter German trial. Reinhardt U, Tulusan A, Angermund R, Lutz H, German Epoetin Alfa Study Group. Oncologist; 2005 Mar; 10(3):225-37. PubMed ID: 15793226 [Abstract] [Full Text] [Related]
23. Effects of epoetin-alpha on quality of life of cancer patients with solid tumors receiving chemotherapy. Christodoulou C, Dafni U, Aravantinos G, Koutras A, Samantas E, Karina M, Janinis J, Papakostas P, Skarlos D, Kalofonos HP, Fountzilas G. Anticancer Res; 2009 Feb; 29(2):693-702. PubMed ID: 19331224 [Abstract] [Full Text] [Related]
24. Pharmacokinetics and pharmacodynamics of once-weekly subcutaneous epoetin alfa in critically ill patients: results of a randomized, double-blind, placebo-controlled trial. Vincent JL, Spapen HD, Creteur J, Piagnerelli M, Hubloue I, Diltoer M, Roman A, Stevens E, Vercammen E, Beaver JS. Crit Care Med; 2006 Jun; 34(6):1661-7. PubMed ID: 16607233 [Abstract] [Full Text] [Related]
26. Response predicting factors to recombinant human erythropoietin in cancer patients undergoing platinum-based chemotherapy. González-Barón M, Ordóñez A, Franquesa R, Constenla M, Montalar J, Gili F, Camps C, Sancho JF, Pérez-Cachot P. Cancer; 2002 Dec 01; 95(11):2408-13. PubMed ID: 12436449 [Abstract] [Full Text] [Related]
36. Effects of early intervention with epoetin alfa on transfusion requirement, hemoglobin level and survival during platinum-based chemotherapy: Results of a multicenter randomised controlled trial. Savonije JH, van Groeningen CJ, van Bochove A, Honkoop AH, van Felius CL, Wormhoudt LW, Giaccone G. Eur J Cancer; 2005 Jul 01; 41(11):1560-9. PubMed ID: 15953714 [Abstract] [Full Text] [Related]
37. Erythropoietin-alfa during neoadjuvant chemotherapy for locally advanced esophagogastric adenocarcinoma. Abbrederis K, Bassermann F, Schuhmacher C, Voelter V, Busch R, Roethling N, Sendler A, Siewert JR, Peschel C, Lordick F. Ann Thorac Surg; 2006 Jul 01; 82(1):293-7. PubMed ID: 16798232 [Abstract] [Full Text] [Related]
38. Recombinant human erythropoietin in pediatric oncology: a review. Feusner J, Hastings C. Med Pediatr Oncol; 2002 Oct 01; 39(4):463-8. PubMed ID: 12203665 [Abstract] [Full Text] [Related]